Burning Rock Biotech (BNR) Return on Sales: 2021-2025
Historic Return on Sales for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to 0.12%.
- Burning Rock Biotech's Return on Sales rose 19.00% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 65.00%. This contributed to the annual value of 0.65% for FY2024, which is 56.00% up from last year.
- Latest data reveals that Burning Rock Biotech reported Return on Sales of 0.12% as of Q3 2025, which was down 97.69% from 0.06% recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Return on Sales registered a high of 0.06% during Q2 2025, and its lowest value of 2.01% during Q2 2022.
- Moreover, its 3-year median value for Return on Sales was 0.79% (2024), whereas its average is 0.70%.
- Its Return on Sales has fluctuated over the past 5 years, first plummeted by 55bps in 2021, then soared by 114bps in 2023.
- Burning Rock Biotech's Return on Sales (MRQ) stood at 1.71% in 2021, then increased by 11bps to 1.52% in 2022, then grew by 14bps to 1.31% in 2023, then soared by 58bps to 0.54% in 2024, then soared by 77bps to 0.12% in 2025.
- Its last three reported values are 0.12% in Q3 2025, 0.06% for Q2 2025, and 0.10% during Q1 2025.